Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: A preliminary report

European Radiology

Volumn 23, Issue 8, 2013, Pages 2206-2214

  Yoshida, Soichiro ^a   Kobayashi, Shuichiro ^a   Koga, Fumitaka ^a   Ishioka, Junichiro ^a   Ishii, Chikako ^b   Tanaka, Hiroshi ^b   Nakanishi, Yasukazu ^a   Matsuoka, Yoh ^a   Numao, Noboru ^a   Saito, Kazutaka ^a   Masuda, Hitoshi ^a   Fujii, Yasuhisa ^a   Kihara, Kazunori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Ochanomizu Surugadai Clinic   (Japan)

Author keywords

Diffusion magnetic resonance imaging; Kidney pelvis; Neoplasm; Prognosis; Ureter

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LABELING INDEX; MALE; NEPHROURETERECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOMA; DIFFUSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PROSPECTIVE STUDIES; RISK; TIME FACTORS; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84880325755     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-2805-2     Document Type: Article

References (36)

1. Schmauz R, Cole P (1974) Epidemiology of cancer of the renal pelvis and ureter. J Natl Cancer Inst 52:1431-1434
2. Abouassaly R, Alibhai SM, Shah N, Timilshina N, Fleshner N, Finelli A (2010) Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology 76:895-901
3. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG (1998) Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52:594-601
4. Olgac S, Mazumdar M, Dalbagni G, Reuter VE (2004) Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol 28:1545-1552
5. Brown GA, Busby JE, Wood CG et al (2006) Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm? BJU Int 98:1176-1180
6. Roupret M, Zigeuner R, Palou J et al (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 59:584-594
7. Chromecki TF, Bensalah K, Remzi M et al (2011) Prognostic factors for upper urinary tract urothelial carcinoma. Nat Rev Urol 8:440-447
8. Hong B, Park S, Hong JH, Kim CS, Ro JY, Ahn H (2005) Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract. Urology 65:692-696
9. Kikuchi E, Horiguchi Y, Nakashima J et al (2005) Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol 174:2120-2123, discussion 2124
10. Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K (2007) Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol 178:2291-2296, discussion 2296
11. Smith AK, Stephenson AJ, Lane BR et al (2011) Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology 78:82-86
12. Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH (2012) High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology 79:615-619
13. Favaretto RL, Shariat SF, Savage C et al (2011) Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int 109:77-82
14. Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188:1622-1635
15. Padhani AR, Liu G, Koh DM et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102-125
16. Yoshida S, Koga F, Kobayashi S et al (2012) Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 83:e21-e27
17. Berrak S, Chawla S, Kim S et al (2011) Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy. Acad Radiol 18:1225-1232
18. Ohno Y, Koyama H, Yoshikawa T et al (2012) Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy. AJR Am J Roentgenol 198:75-82
19. Pope WB, Lai A, Mehta R et al (2011) Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. AJNR Am J Neuroradiol 32:882-889
20. Srinivasan A, Chenevert TL, Dwamena BA et al (2012) Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma. J Comput Assist Tomogr 36:131-137
21. Wieduwilt MJ, Valles F, Issa S et al (2012) Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. Clin Cancer Res 18:1146-1155
22. Yoshida S, Masuda H, Ishii C, Saito K, Kawakami S, Kihara K (2008) Initial experience of functional imaging of upper urinary tract neoplasm by diffusion-weighted magnetic resonance imaging. Int J Urol 15:140-143
23. Akita H, Jinzaki M, Kikuchi E et al (2011) Preoperative T categorization and prediction of histopathologic grading of urothelial carcinoma in renal pelvis using diffusion-weighted MRI. AJR Am J Roentgenol 197:1130-1136
24. Nishizawa S, Imai S, Okaneya T, Nakayama T, Kamigaito T, Minagawa T (2010) Diffusion weighted imaging in the detection of upper urinary tract urothelial tumors. Int Braz J Urol 36:18-28
25. Takeuchi M, Suzuki T, Sasaki S et al (2012) Clinicopathologic significance of high signal intensity on diffusion-weighted MR imaging in the ureter, urethra, prostate and bone of patients with bladder cancer. Acad Radiol 19:827-833
26. Yoshida S, Masuda H, Ishii C et al (2011) Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer. AJR Am J Roentgenol 196:110-116
27. Matsuki M, Inada Y, Tatsugami F, Tanikake M, Narabayashi I, Katsuoka Y (2007) Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol 17:201-204
28. Daggulli M, Onur MR, Firdolas F, Onur R, Kocakoc E, Orhan I (2011) Role of diffusion MRI and apparent diffusion coefficient measurement in the diagnosis, staging and pathological classification of bladder tumors. Urol Int 87:346-352
29. Kobayashi S, Koga F, Yoshida S et al (2011) Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol 21:2178-2186
30. Takeuchi M, Sasaki S, Ito M et al (2009) Urinary bladder cancer: diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade. Radiology 251:112-121
31. Avcu S, Koseoglu MN, Ceylan K, Bulut MD, Unal O (2011) The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions. Br J Radiol 84:875-882
32. Sufana Iancu A, Colin P, Puech P et al (2012) Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI. World J Urol. doi: 10.1007/s00345-012-0945-7
33. Sobin LHWC (2002) TNM classification of malignant tumours, 6th edn. Wiley-Liss, New York
34. WHO (1988) International histological classification of tumours, 2nd edn. Springer, Berlin
35. Kamai T, Takagi K, Asami H, Ito Y, Arai K, Yoshida KI (2000) Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter. BJU Int 86:14-19
36. Yoshida S, Koga F, Kawakami S et al (2010) Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology 75:387-391